Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product...

17
Development of the VITROS HIV Combo assay Patrick Kilmartin Product Development

Transcript of Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product...

Page 1: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

Development of the VITROS HIV Combo assay

Patrick KilmartinProduct Development

Page 2: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

2

Development of the VITROS HIV Combo assay

© Ortho-Clinical Diagnostics, Inc.

Page 3: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

3© Ortho-Clinical Diagnostics, Inc.

Introduction

Page 4: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

4

Assay design and timing

© Ortho-Clinical Diagnostics, Inc.

Page 5: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

5

Antibody Sensitivity

© Ortho-Clinical Diagnostics, Inc.

Page 6: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

6

Seroconversion sensitivity

© Ortho-Clinical Diagnostics, Inc.

Page 7: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

7

HIV-1 p24 Ag sensitivity

© Ortho-Clinical Diagnostics, Inc.

Page 8: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

8

Detection of HIV-1 antigen genotypesdilutions of HIV-1 Group M & O virus

© Ortho-Clinical Diagnostics, Inc.

Page 9: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

9

Specificity

© Ortho-Clinical Diagnostics, Inc.

Page 10: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

10

Specificity

© Ortho-Clinical Diagnostics, Inc.

Page 11: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

11

Specificity- summary

© Ortho-Clinical Diagnostics, Inc.

Page 12: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

12

Other considerations

© Ortho-Clinical Diagnostics, Inc.

Key focus of assay development activities at OCD is to ensure consistent results lot to lot and instrument to instrumentCalibrators - are optimized to consistently position cut off whilst

supporting 28 day calibration interval and excellent long term stability.Coated Wells - Coating methods optimized to ensure consistent

clinical and analytical performance lot-lot.Reagents - Formulations optimized to ensure consistent clinical and

technical performance, a high degree of protection against interference from “problem samples” such as anti-HRP activity, heterophilic antibodies, HAMA and RF. Excellent Sensitivity Excellent Specificity

Secure manufacturing processes with appropriate documentation aligned with J&J and FDA Quality Systems regulations—very successful FDA GMP inspections

Page 13: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

13

VITROS® Systems

© Ortho-Clinical Diagnostics, Inc.

Page 14: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

14

System features that benefit HIV testing

© Ortho-Clinical Diagnostics, Inc.

Disposable tip sample metering Clot detection Bubble detection Short sample detection High/low viscosity detection

Sample + Reagent Verification Well Wash Dispense Verification Signal Reagent Dispense Verification

Page 15: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

15

6

7

98

IntelliReport

Reports the quality of each result

Lumino-meter

9

AddReagent 2

AddReagent 1

Well Shuttle to Inner Ring

Incubation

4

Discard to waste

1

3

Microwell Dispense

1

Sample Metering

2

Reagent Metering

3

SignalReagent

7

Incubate4.5 mins

8Microwell

Wash

6

AddSample

10 5

10

42

Intellicheck® Technology

Page 16: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

16

MicroSensor Technology – Sample Indices

© Ortho-Clinical Diagnostics, Inc.

Page 17: Development of the VITROS HIV Combo assay of the VITROS HIV Combo assay Patrick Kilmartin Product Development

17

Conclusions

© Ortho-Clinical Diagnostics, Inc.